A BILL 
To expand the tropical disease product priority review vouch-
er program to encourage treatments for the Middle East 
respiratory syndrome, Nipah, and Rift Valley fever. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Adding Epidemic Dis-
4
eases to the FDA Priority Review Voucher Program Act’’. 
5
21:58 Oct 02, 2019
H4553
2 
•HR 4553 IH
SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRI-
1
ORITY REVIEW VOUCHER PROGRAM TO EN-
2
COURAGE TREATMENTS FOR MIDDLE EAST 
3
RESPIRATORY SYNDROME, NIPAH, AND RIFT 
4
VALLEY FEVER. 
5
Section 524(a)(3) of the Federal Food, Drug, and 
6
Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— 
7
(1) by redesignating subparagraph (S) as sub-
8
paragraph (V); and 
9
(2) by inserting after subparagraph (R) the fol-
10
lowing: 
11
‘‘(S) Middle East respiratory syndrome. 
12
‘‘(T) Nipah. 
13
‘‘(U) Rift Valley fever.’’. 
14
Æ 
21:58 Oct 02, 2019
H4553
